Lantern Pharma Unveils Roadmap for withZeta.ai — Industry-First, Multi-Agentic Co-Scientist Featuring Swarm Intelligence and Computational Biology Toolkit with the Launch of ZetaSwarm™ and ZetaOmics™

$LTRNPress releaseMay 7, 2026, 9:01 AM ETRead the release

Lantern Pharma announced that its AI co-scientist platform, withZeta.ai, is now commercially available via a subscription model, targeting the $15 billion market for AI drug discovery tools. The company unveiled a roadmap for upcoming capabilities including ZetaSwarm, a multi-agent swarm intelligence layer, and ZetaOmics, a real-time computational biology toolkit.

Key figures

Market size usd: $15 billion
Agent configurations: 15
Existing tools count: 34

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.